Int J Stomatol ›› 2021, Vol. 48 ›› Issue (2): 141-146.doi: 10.7518/gjkq.2021045
• Oral Medicine • Previous Articles Next Articles
Liu Siyu1,2(),Li Xin3,Xu Xiaoyu1,Sun Yinyin1,Pan Yingxiao4,Wang Sainan5,Lu Shulai2()
CLC Number:
[1] | 陈谦明. 口腔黏膜病学[M]. 4版. 北京: 人民卫生出版社, 2013: 103-110. |
Chen QM. Oral mucosal diseases[M]. 4th ed. Beijing: People,s Medical Publishing House, 2013: 103-110. | |
[2] |
Ofori-Asenso R, Garcia D. Cardiovascular diseases in Ghana within the context of globalization[J]. Cardiovasc Diagn Ther, 2016,6(1):67-77.
doi: 10.3978/j.issn.2223-3652.2015.09.02 pmid: 26885494 |
[3] |
Dreiher J, Shapiro J, Cohen AD. Lichen planus and dyslipidaemia: a case-control study[J]. Br J Dermatol, 2009,161(3):626-629.
pmid: 19438850 |
[4] |
Arias-Santiago S, Buendía-Eisman A, Aneiros-Fer-nández J, et al. Lipid levels in patients with lichen planus: a case-control study[J]. J Eur Acad Dermatol Venereol, 2011,25(12):1398-1401.
doi: 10.1111/j.1468-3083.2011.03983.x pmid: 21348899 |
[5] |
Aniyan KY, Guledgud MV, Patil K. Alterations of serum lipid profile patterns in oral lichen planus patients: a case-control study[J]. Contemp Clin Dent, 2018,9(Suppl 1):S112-S121.
doi: 10.4103/ccd.ccd_111_18 pmid: 29962775 |
[6] | López-Jornet P, Camacho-Alonso F, Rodríguez-Mar-tínes MA. Alterations in serum lipid profile patterns in oral lichen planus: a cross-sectional study[J]. Am J Clin Dermatol, 2012,13(6):399-404. |
[7] |
Ozbagcivan O, Akarsu S, Semiz F, et al. Comparison of serum lipid parameters between patients with classic cutaneous lichen planus and oral lichen planus[J]. Clin Oral Investig, 2020,24(2):719-725.
doi: 10.1007/s00784-019-02961-6 pmid: 31129877 |
[8] |
Sahin M, Bilgili SG, Simsek H, et al. Increased P-wave dispersion in patients with newly diagnosed lichen planus[J]. Clinics (Sao Paulo), 2013,68(6):846-850.
doi: 10.6061/clinics |
[9] |
Aditi R, Sathasivasubramanian S, Bhaskar ME. Association of oral lichen planus and electrocardiographic P-wave dispersion-an original research[J]. Braz Dent J, 2017,28(6):699-703.
pmid: 29211124 |
[10] |
Rashed L, Abdel Hay R, AlKaffas MM, et al. Studying the association between methylenetetrahydrofolate reductase (MTHFR) 677 gene polymorphism, cardiovascular risk and lichen planus[J]. J Oral Pathol Med, 2017,46(10):1023-1029.
doi: 10.1111/jop.12588 pmid: 28463405 |
[11] |
Aksu F, Karadag AS, Caliskan M, et al. Does lichen planus cause increased carotid intima-media thickness and impaired endothelial function[J]. Can J Cardiol, 2016, 32(10): 1246.e1-1246.e6.
doi: 10.1016/j.cjca.2015.11.016 |
[12] | 潘蕾. 口腔扁平苔藓患者心血管疾病风险研究[D]. 上海: 上海交通大学, 2016. |
Pan L. A research about risk of cardiovascular disea-ses of patients with oral lichen planus[D]. Shanghai: Shanghai Jiao Tong University, 2016. | |
[13] |
Grinspan D, Diaz J, Villapol Lo, et al. Lichen ruber planus of the buccal mucosa. Its association with diabetes[J]. Bull Soc Fr Dermatol Syphiligr, 1966,73(6):898-899.
pmid: 5987868 |
[14] |
Sallay K, Kövesi G, Döri F. Circulating immune complex studies on patients with oral lichen planus[J]. Oral Surg Oral Med Oral Pathol, 1989,68(5):567-570.
doi: 10.1016/0030-4220(89)90241-7 pmid: 2812711 |
[15] |
Kumar P, Mastan K, Chowdhary R, et al. Oral manifestations in hypertensive patients: a clinical study[J]. J Oral Maxillofac Pathol, 2012,16(2):215-221.
doi: 10.4103/0973-029X.99069 pmid: 22923893 |
[16] |
Mozaffari HR, Sharifi R, Sadeghi M. Prevalence of oral lichen planus in diabetes mellitus: a meta-analysis study[J]. Acta Inform Med, 2016,24(6):390-393.
doi: 10.5455/aim.2016.24.390-393 pmid: 28077900 |
[17] | Ahmed I, Nasreen S, Jehangir U, et al. Frequency of oral lichen planus in patients with noninsulin dependent diabetes mellitus[J]. J Pak Assoc Derm, 2017,22(1):30-34. |
[18] |
Nazir MA, AlGhamdi L, AlKadi M, et al. The burden of diabetes, its oral complications and their prevention and management[J]. Open Access Maced J Med Sci, 2018,6(8):1545-1553.
doi: 10.3889/oamjms.2018.294 pmid: 30159091 |
[19] |
Kalkur C, Sattur AP, Guttal KS. Role of depression, anxiety and stress in patients with oral lichen planus: a pilot study[J]. Indian J Dermatol, 2015,60(5):445-449.
doi: 10.4103/0019-5154.159625 pmid: 26538689 |
[20] |
Pippi R, Romeo U, Santoro M, et al. Psychological disorders and oral lichen planus: matched case-control study and literature review[J]. Oral Dis, 2016,22(3):226-234.
doi: 10.1111/odi.12423 pmid: 26680999 |
[21] |
Vilar-Villanueva M, Gándara-Vila P, Blanco-Aguilera E, et al. Psychological disorders and quality of life in oral lichen planus patients and a control group[J]. Oral Dis, 2019,25(6):1645-1651.
doi: 10.1111/odi.13106 pmid: 30993798 |
[22] |
Gupta S, Jawanda MK. Oral lichen planus: an update on etiology, pathogenesis, clinical presentation, diagnosis and management[J]. Indian J Dermatol, 2015,60(3):222-229.
doi: 10.4103/0019-5154.156315 pmid: 26120146 |
[23] |
Joseph P, Leong D, McKee M, et al. Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors[J]. Circ Res, 2017,121(6):677-694.
doi: 10.1161/CIRCRESAHA.117.308903 pmid: 28860318 |
[24] |
Kurago ZB. Etiology and pathogenesis of oral lichen planus: an overview[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2016,122(1):72-80.
doi: 10.1016/j.oooo.2016.03.011 pmid: 27260276 |
[25] |
Karatsaidis A, Hayashi K, Schreurs O, et al. Survival signalling in keratinocytes of erythematous oral lichen planus[J]. J Oral Pathol Med, 2007,36(4):215-222.
doi: 10.1111/j.1600-0714.2007.00519.x pmid: 17391299 |
[26] |
Kaur J, Jacobs R. Proinflammatory cytokine levels in oral lichen planus, oral leukoplakia, and oral submucous fibrosis[J]. J Korean Assoc Oral Maxillofac Surg, 2015,41(4):171-175.
doi: 10.5125/jkaoms.2015.41.4.171 pmid: 26339574 |
[27] | 肖述铜, 徐凡, 黄卫东. 心血管疾病与牙周炎关系的研究进展[J]. 临床口腔医学杂志, 2018,34(2):120-122. |
Xiao ST, Xu F, Huang WD. Research progress on the relationship between cardiovascular disease and periodontitis[J]. J Clin Stomatol, 2018,34(2):120-122. | |
[28] |
Gu GM, Martin MD, Darveau RP, et al. Oral and serum IL-6 levels in oral lichen planus patients[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2004,98(6):673-678.
doi: 10.1016/j.tripleo.2004.05.006 pmid: 15583539 |
[29] |
Mozaffari HR, Sharifi R, Sadeghi M. Interleukin-6 levels in the serum and saliva of patients with oral lichen planus compared with healthy controls: a meta-analysis study[J]. Cent Eur J Immunol, 2018,43(1):103-108.
doi: 10.5114/ceji.2018.74880 pmid: 29731693 |
[30] |
Saleh N, Samir N, Megahed H, et al. Homocysteine and other cardiovascular risk factors in patients with lichen planus[J]. J Eur Acad Dermatol Venereol, 2014,28(11):1507-1513.
doi: 10.1111/jdv.12329 pmid: 24330130 |
[31] |
Chen HM, Wang YP, Chang JY, et al. Significant association of deficiencies of hemoglobin, iron, folic acid, and vitamin B12 and high homocysteine level with oral lichen planus[J]. J Formos Med Assoc, 2015,114(2):124-129.
doi: 10.1016/j.jfma.2014.10.004 pmid: 25557154 |
[32] |
Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease[J]. Nutr J, 2015,14:6.
doi: 10.1186/1475-2891-14-6 pmid: 25577237 |
[33] | Lominadze D, Dean WL, Tyagi SC, et al. Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease[J]. Acta Physiol (Oxf), 2010,198(1):1-13. |
[34] |
Kamath DY, Xavier D, Sigamani A, et al. High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: an Indian perspective[J]. Indian J Med Res, 2015,142(3):261-268.
doi: 10.4103/0971-5916.166582 pmid: 26458341 |
[35] |
Santoro A, Majorana A, Bardellini E, et al. NF‐kappa B expression in oral and cutaneous lichen planus[J]. J Pathol, 2003,201(3):466-472.
doi: 10.1002/path.1423 pmid: 14595759 |
[36] |
Yu XH, Zheng XL, Tang CK. Nuclear factor-κB activation as a pathological mechanism of lipid metabolism and atherosclerosis[J]. Adv Clin Chem, 2015,70:1-30.
doi: 10.1016/bs.acc.2015.03.004 pmid: 26231484 |
[37] |
Gupta S, Ghosh S, Gupta S. Interventions for the management of oral lichen planus: a review of the conventional and novel therapies[J]. Oral Dis, 2017,23(8):1029-1042.
doi: 10.1111/odi.12634 pmid: 28055124 |
[38] |
Habbab KM, Moles DR, Porter SR. Potential oral manifestations of cardiovascular drugs[J]. Oral Dis, 2010,16(8):769-773.
doi: 10.1111/j.1601-0825.2010.01686.x pmid: 20604876 |
[39] |
Balakumar P, Kavitha M, Nanditha S. Cardiovascular drugs-induced oral toxicities: a murky area to be revisited and illuminated[J]. Pharmacol Res, 2015,102:81-89.
doi: 10.1016/j.phrs.2015.09.007 pmid: 26409645 |